Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2014

May 16, 2014

34519_dirs_2014-05-16_df30c6f0-173f-4129-9b87-c89561e52e16.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2014-05-15

Reporting Person: Tomsche David Scott (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-15 Common Stock, par value $0.10 per share P 1000 $3.51 Acquired 53668 Direct
2014-05-15 Common Stock, par value $0.10 per share P 1000 $3.63 Acquired 54668 Direct
2014-05-15 Common Stock, par value $0.10 per share P 1000 $3.5 Acquired 55668 Direct
2014-05-15 Common Stock, par value $0.10 per share P 1000 $3.71 Acquired 56668 Direct

Footnotes

F1: (1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.